Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2023 Earnings Call Transcript

Jazz Pharmaceuticals plc misses on earnings expectations. Reported EPS is $5.02 EPS, expectations were $5.26.

Related Keywords

United States ,Japan ,Japanese ,America ,Ashish Verma ,Bruce Cozadd ,Andrea Flynn ,Marc Goodman ,Jessica Fye ,David Amsellem ,Eli Lilly ,Philip Johnson ,Jason Gerberry ,Annabel Samimy ,Joseph Thome ,Piper Sandler ,Gregory Renza ,Rob Iannone ,Group Vice ,Genentech ,Needham Company ,Jp Morgan ,Jazz Pharmaceuticals ,Jazz Pharmaceuticals Fourth Quarter ,Amgen ,Nasdaq ,Jazz Pharmaceuticals Plc ,Call Transcript February ,Chief Executive Officer ,Renee Gala ,Chief Operating Officer ,Executive Vice President ,Global Head ,Chief Financial Officer ,Group Vice President ,Digital Media Stocks To Buy ,Buy According ,Erwiniai M ,Ami Fadia ,Thanks Ami ,